Hydrocortisone / Latanoprost / Minoxidil / Tretinoin / Vit E

(HLMT-VIT E for Women) Solution

1% / 0.05% / 6% / 0.01% / 1%

Ready to prescribe?
Disclaimer: Images are for reference only; actual products may vary.

Product Overview

This topical formulation for women combines hydrocortisone, latanoprost, minoxidil, tretinoin, and vitamin E into a solution to promote hair regrowth, reduce inflammation, and nourish the scalp.   Each ingredient has a unique mechanism of action to support development and growth of hair.  This formulation is designed to enhance follicle activity and protect against oxidative stress, it supports healthier, fuller hair with consistent use.

Hydrocortisone1,2

Hydrocortisone is a synthetic version of cortisol, a hormone produced by the adrenal glands, and possesses both glucocorticoid and mineralocorticoid activity. When used topically, hydrocortisone exhibits anti-inflammatory, antipruritic, anti-mitotic, and immunosuppressive effects. Among topical corticosteroids, hydrocortisone is considered a low-potency option.

Latanoprost3-7

Latanoprost acts as an analogue of prostaglandin F2α (PGF2α). It is used in glaucoma management and has also been observed to influence hair growth. Findings have noted its effects in areas such as androgenetic alopecia and eyelash or eyebrow hypotrichosis. Interest in its role in hair growth originally stemmed from reports of enhanced eyelash growth in individuals using it for glaucoma.

Minoxidil8-10

Topical minoxidil is a vasodilatory compound originally developed as an oral antihypertensive agent. It was found to stimulate hair growth (from the observation of hypertrichosis (excessive, abnormal hair growth) in patients taking oral minoxidil) and was subsequently FDA approved for androgenetic alopecia (male and female pattern hair loss).

Tretinoin11-14

Tretinoin, a naturally occurring derivative of vitamin A, is also known as all-trans-retinoic acid. Retinoids may participate in regulating cell reproduction, proliferation, and differentiation. When used alongside minoxidil, tretinoin has been associated with increased expression of certain markers linked to hair growth (such as Erk, Akt, Bcl-2, and Bax).

Vitamin E15

Vitamin E (tocopherol) is a fat-soluble antioxidant that contributes to protecting cell membranes. Because the body does not synthesize vitamin E, it must be obtained externally. It may limit the formation of reactive oxygen species and help maintain collagen and glycosaminoglycan synthesis in the skin. Vitamin E has been studied in connection with several dermatologic conditions, including atopic dermatitis, epidermolysis bullosa, psoriasis, wound care, melasma, scleroderma, and acne vulgaris.

Hydrocortisone1,2

The anti-inflammatory effects of topical hydrocortisone may occur through vasoconstriction. The vasoconstriction minimizes inflammatory mediators delivered to the inflamed area. Topical hydrocortisone may also inhibit the release of phospholipase A2, which reduces prostaglandins and leukotriene. Lastly, topical hydrocortisone inhibits DNA and transcription factors related to inflammation. It does this by increasing the expression of anti-inflammatory genes and indirectly inhibit inflammatory transcription factors, such as NF-kB, to decrease the expression of pro-inflammatory genes.

Topical hydrocortisone also has an anti-mitotic effect by decreasing epidermal mitosis mediated through an increase in lipocortin, an endogenous glucocorticoid-regulated protein.

Topical hydrocortisone also inhibits humoral factors in the inflammatory response by suppressing immune cells from maturing, differentiating and proliferating.

Latanoprost3-7

Latanoprost binds to the prostaglandin F2α receptor on hair follicle dermal papilla cells, influencing the hair growth cycle as follows:

  1. Prolongation of Anagen Phase (Growth Phase):

Increases the duration of anagen, which may result in longer and thicker hair shafts.

  1. Stimulation of Melanogenesis:

May enhance pigmentation in vellus hairs, which may make them appear darker and more terminal-like.

  1. Increased Follicular Density:

Some studies suggest latanoprost may increase the number of follicles actively producing hair, particularly in the eyelash and eyebrow regions, and potentially the scalp.

Minoxidil8-10

The drug has many mechanisms in supporting hair growth:

  • Potassium channel opening: Minoxidil is a K⁺-ATP channel opener, which may result in vasodilation and enhanced blood flow to hair follicles.
  • Prolongation of the hair cycle: It may extend the growth phase of the hair cycle, leading to increased follicle size and more robust hair shafts.
  • Activation of prostaglandins: May indirectly affect prostaglandin-mediated signaling to stimulate hair follicle activity.
  • Upregulation of vascular endothelial growth factor (VEGF): Promotes angiogenesis in dermal papillae, which may improve follicular nourishment.

Tretinoin11-14

Tretinoin may have several mechanisms to facilitate hair growth including the following:

  • Cell turnover-Tretinoin facilitates skin cell turnover which may open up hair follicles for hair growth
  • Enhanced absorption-Tretinoin may help absorption of minoxidil. This may be from the increased absorption of minoxidil which may be the result of increased sulfonation.
  • Prolong anagen phase-Tretinoin may help lengthen the growth phase of hair follicles.

Vitamin E15

  • Gamma (γ) tocopherol is the most abundant vitamin E in the diet and alpha (α) tocopherol is the most abundant form of vitamin E in the skin. These forms of vitamin E are thought to inhibit the production of prostaglandin and nitric oxide, protect skin cells from sunburn and generally prevent oxidative stress in the skin.

Hydrocortisone1,2

Common

  • Skin irritation, pruritus, dry skin, folliculitis, hair growth, acne

Latanoprost6,7

Common

  • Local irritation (itching, burning, erythema)
  • Hyperpigmentation of skin (especially around eyelids or eyebrows)
  • Increased pigmentation of treated hair
  • Eyelid darkening (rare with scalp use)
  • Unwanted hair growth if medication spreads to unintended areas
  • Eye irritation (if it migrates to eye area)

 

Minoxidil8-10

Common

Topical minoxidil is generally well tolerated but may cause local effects:

  • Scalp irritation, dryness, flaking
  • Erythema or contact dermatitis (more common with propylene glycol-containing formulations)
  • Pruritus or burning sensation
  • Unwanted facial hair growth (esp. in women or if solution drips onto other areas)

 

Tretinoin11

Common

  • Skin irritation, such as peeling, xerosis (dry skin), burning, stinging, erythema, and pruritus

Contraindications1,2,6,7,8-11

  • Known hypersensitivity or intolerance to hydrocortisone, latanoprost, minoxidil, tretinoin, vitamin E or excipients
  • Contraindicated in women who are or may become pregnant if absorbed systemically due to risk of teratogenicity

Precautions1,2,6,7,8-11

  • Not recommended to be applied to open wounds

Store at room temperatures between (59-86°F). Protect from light and keep the container tightly closed. Keep out of reach of children and pets.

  1. Clinical Pharmacology hydrocortisone clinical monograph 2025 https://www.clinicalkey.com/pharmacology/     Accessed August 15, 2025
  2. Gabros S, Nessel TA. Topical Corticosteroids. April 26, 2025. Accessed July 27, 2025.
  3. Johnstone, M. A. (1997). Hypertrichosis and increased pigmentation of eyelashes and adjacent hair in latanoprost therapy. American Journal of Ophthalmology, 120(7), 999–1001.
  4. Blume-Peytavi, U., et al. (2012). Latanoprost stimulates human scalp hair growth in vivo. Journal of the American Academy of Dermatology, 66(5), 807–814.
  5. Kwon, O. S., et al. (2007). Prostaglandin analogs as a potential treatment for hair loss: Latanoprost and bimatoprost in the management of alopecia. International Journal of Dermatology, 46(9), 1044–1048.
  6. Clinical Pharmacology. Elsevier. Latanoprost Monograph. Accessed August 15, 2025
  7. FDA Drug Label: Xalatan (latanoprost ophthalmic solution) https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=a98595b3-9f47- 48e0-b18d-550a2095f264&type=display Revised May 2023. Accessed June 15, 2025
  8. Clinical Pharmacology [Internet].: Elsevier; accessed May 2025; Minoxidil topical monograph. Available from: ClinicalKey; https://www.clinicalkey.com/pharmacology/monograph/408?n=Minoxidil
  9. Rogaine® (minoxidil topical solution) package insert. Johnson & Johnson Consumer Inc. https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=12fd18f0-859c-7b9a-e063-6394a90addbf&type=display Revised March 2024. Accessed June 16, 2025
  10. Goren A, Naccarato T. Minoxidil in the treatment of androgenetic alopecia. Dermatol Ther. 2018 Sep;31(5):e12686.
  11. Clinical Pharmacology tretinoin clinical monograph 2025 https://www.clinicalkey.com/pharmacology/
  12. Yoham AL, Casadesus D. Tretinoin. March 27, 2023. Accessed July 27, 2025.
  13. Sharma A, Goren A, Dhurat R, Agrawal S, Sinclair R, Trüeb RM, Vañó-Galván S, Chen G, Tan Y, Kovacevic M, Situm M, McCoy J. Tretinoin enhances minoxidil response in androgenetic alopecia patients by upregulating follicular sulfotransferase enzymes. Dermatol Ther. 2019 May;32(3):e12915.
  14. Can Tretinoin Help with Hair Growth? https://cityskinclinic.com/tretinoin-hair-growth/ June 12, 2025. Accessed August 15, 2025
  15. Keen MA, Hassan I. Vitamin E in dermatology. Indian Dermatol Online J. 2016 Jul-Aug;7(4):311-5.

WPPL operates as a 503A compounding pharmacy and prepares individualized prescription medications pursuant to provider direction. Compounded preparations are not reviewed, tested, or approved by the FDA.

This listing also includes commercially manufactured products for convenience; these items are not compounded by our pharmacy and are sold as provided by their manufacturers. Any statements regarding non-compounded products are manufacturer-supplied, have not been evaluated by the FDA, and are not intended to diagnose, treat, cure, or prevent any disease. WPPL does not verify or endorse any therapeutic claims made by manufacturers. Please refer to original labeling for complete product information.

EXPLORE MORE

Related Medications

Licensed to ship across the U.S.

Your orders arrive promptly and privately, delivered directly to your door.

Providers: Let’s Partner for Better Patient Care

If you are a physician, clinic, or practice seeking a dependable Compounding Pharmacy partner, WP Pharma Labs is here to help. With dedicated account setup, streamlined ordering and responsive service, we support your therapeutic goals with specialized compounds designed for your patients.

To check product availability, check on the status of an existing order, request refills:
orders@wppharmalabs.com

New providers setup / update an existing account:
newaccounts@wppharmalabs.com